home / stock / etnb / etnb short
Short Information | 89bio Inc. (NYSE:ETNB)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 28,863 |
Total Actual Volume | 884,534 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 1,443 |
Average Short Percentage | 3.40% |
Is there a ETNB Short Squeeze or Breakout about to happen?
See the ETNB Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
02-12-2020 | $28.80 | $29.30 | $31.19 | $27.76 | 11,196 | 946 | 8.45% |
02-11-2020 | $27.31 | $28.60 | $28.85 | $26.32 | 23,681 | 902 | 3.81% |
02-10-2020 | $26.00 | $26.79 | $27.03 | $25.975 | 10,861 | 369 | 3.4% |
02-07-2020 | $27.03 | $25.99 | $27.97 | $25.7352 | 28,923 | 789 | 2.73% |
02-06-2020 | $26.45 | $27.53 | $27.77 | $25.955 | 37,417 | 314 | 0.84% |
02-05-2020 | $27.20 | $26.36 | $29.00 | $26.17 | 64,450 | 281 | 0.44% |
02-04-2020 | $26.05 | $26.90 | $27.9661 | $25.3972 | 54,208 | 3,083 | 5.69% |
02-03-2020 | $27.00 | $25.90 | $28.84 | $25.261 | 49,774 | 1,514 | 3.04% |
01-31-2020 | $30.52 | $26.72 | $31.99 | $25.24 | 72,888 | 400 | 0.55% |
01-30-2020 | $34.02 | $30.37 | $35.712 | $29.50 | 74,218 | 1,645 | 2.22% |
01-29-2020 | $27.83 | $33.66 | $34.93 | $26.76 | 94,874 | 8,153 | 8.59% |
01-28-2020 | $27.72 | $27.34 | $27.88 | $27.00 | 15,868 | 40 | 0.25% |
01-27-2020 | $25.61 | $27.18 | $28.69 | $25.60 | 30,621 | 953 | 3.11% |
01-24-2020 | $27.80 | $26.15 | $27.835 | $25.80 | 13,544 | 380 | 2.81% |
01-23-2020 | $28.60 | $27.92 | $28.90 | $26.2703 | 28,592 | 1,897 | 6.63% |
01-22-2020 | $27.10 | $28.21 | $29.48 | $27.095 | 42,240 | 3,819 | 9.04% |
01-21-2020 | $26.51 | $27.60 | $27.87 | $25.4245 | 28,053 | 700 | 2.5% |
01-17-2020 | $25.63 | $26.51 | $26.8266 | $25.63 | 23,570 | 300 | 1.27% |
01-16-2020 | $26.70 | $25.61 | $27.01 | $24.60 | 118,105 | 1,467 | 1.24% |
01-15-2020 | $27.25 | $26.60 | $28.02 | $25.93 | 61,451 | 911 | 1.48% |
News, Short Squeeze, Breakout and More Instantly...
2024-06-21 09:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
SAN FRANCISCO, May 22, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced that data from the 48-week exten...
—With the initiation of ENLIGHTEN-Cirrhosis, pegozafermin is the first FGF21 analog to enter a Phase 3 trial in MASH patients with compensated cirrhosis (F4)— —Regression of fibrosis by histology at month 24 will serve as the basis for potential accelerated approval...